- Home
- AUUD vs BDRX Comparison
AUUD vs BDRX Comparison
Compare AUUD & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- BDRX
- Stock Information
- Founded
- AUUD 2012
- BDRX 2000
- Country
- AUUD United States
- BDRX United Kingdom
- Employees
- AUUD N/A
- BDRX N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- BDRX Health Care
- Exchange
- AUUD Nasdaq
- BDRX Nasdaq
- Market Cap
- AUUD 4.1M
- BDRX 4.6M
- IPO Year
- AUUD 2021
- BDRX N/A
- Fundamental
- Price
- AUUD $1.22
- BDRX $5.39
- Analyst Decision
- AUUD
- BDRX
- Analyst Count
- AUUD 0
- BDRX 0
- Target Price
- AUUD N/A
- BDRX N/A
- AVG Volume (30 Days)
- AUUD 2.0M
- BDRX 487.9K
- Earning Date
- AUUD 11-07-2025
- BDRX 09-12-2025
- Dividend Yield
- AUUD N/A
- BDRX N/A
- EPS Growth
- AUUD N/A
- BDRX N/A
- EPS
- AUUD N/A
- BDRX N/A
- Revenue
- AUUD N/A
- BDRX N/A
- Revenue This Year
- AUUD N/A
- BDRX N/A
- Revenue Next Year
- AUUD N/A
- BDRX N/A
- P/E Ratio
- AUUD N/A
- BDRX N/A
- Revenue Growth
- AUUD N/A
- BDRX N/A
- 52 Week Low
- AUUD $1.22
- BDRX $5.00
- 52 Week High
- AUUD $14.60
- BDRX $92.00
- Technical
- Relative Strength Index (RSI)
- AUUD 29.98
- BDRX 36.45
- Support Level
- AUUD $1.22
- BDRX $5.00
- Resistance Level
- AUUD $1.37
- BDRX $7.84
- Average True Range (ATR)
- AUUD 0.15
- BDRX 0.64
- MACD
- AUUD -0.02
- BDRX -0.29
- Stochastic Oscillator
- AUUD 5.79
- BDRX 3.01
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.